{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:32:54Z","timestamp":1793385174973,"version":"4.5.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jad.2026.122322","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T06:10:30Z","timestamp":1785132630000},"page":"122322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Pharmacological treatment of late-life major depressive disorder \u2013 Results from the AMSP drug surveillance program from 2007 to 2023"],"prefix":"10.1016","volume":"414","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3262-8137","authenticated-orcid":false,"given":"Martin","family":"Schulze Westhoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8859-6907","authenticated-orcid":false,"given":"Sermin","family":"Toto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5004-3824","authenticated-orcid":false,"given":"Stefan","family":"Bleich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0740-6703","authenticated-orcid":false,"given":"Renate","family":"Grohmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8678-7419","authenticated-orcid":false,"given":"Johanna","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2026.122322_bb0005","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-019-0514-6","article-title":"Mechanisms and treatment of late-life depression","author":"Alexopoulos","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2026.122322_bb0010","article-title":"Updated AGS Beers Criteria\u00ae for POTENTIALLY INAPPROPRIATE MEDICATION USE in OLDER ADULTS, 2023","volume":"71","author":"American Geriatrics Society","year":"2023","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.jad.2026.122322_bb0015","doi-asserted-by":"crossref","DOI":"10.1080\/03007995.2025.2505692","article-title":"Vortioxetine in the routine management of major depressive disorder: an analysis of European automated healthcare databases","volume":"41","author":"Andersohn","year":"2025","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jad.2026.122322_bb0020","doi-asserted-by":"crossref","DOI":"10.1186\/s40360-017-0183-0","article-title":"High prevalence of prescription of psychotropic drugs for older patients in a general hospital","volume":"18","author":"Arnold","year":"2017","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.jad.2026.122322_bb0025","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyab066","article-title":"The choice of either quetiapine or aripiprazole as augmentation treatment in a European naturalistic sample of patients with major depressive disorder","volume":"25","author":"Bartova","year":"2022","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2026.122322_bb0030","doi-asserted-by":"crossref","DOI":"10.1017\/S0033291797005734","article-title":"Consequences of major and minor depression in later life: a study of disability, well-being and service utilization","volume":"27","author":"Beekman","year":"1997","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2026.122322_bb0035","doi-asserted-by":"crossref","DOI":"10.1093\/gerona\/58.3.M249","article-title":"Depression in late life: review and commentary","author":"Blazer","year":"2003","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.jad.2026.122322_bb0040","doi-asserted-by":"crossref","DOI":"10.3399\/BJGPO.2021.0020","article-title":"Trends and variation in antidepressant prescribing in English primary care: a retrospective longitudinal study","volume":"5","author":"Bogowicz","year":"2021","journal-title":"BJGP Open"},{"key":"10.1016\/j.jad.2026.122322_bb0045","doi-asserted-by":"crossref","DOI":"10.1007\/s11920-009-0006-0","article-title":"Metabolic risks in older adults receiving second-generation antipsychotic medication","author":"Brooks","year":"2009","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.jad.2026.122322_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2019.03.057","article-title":"Treatment response of lithium augmentation in geriatric compared to non-geriatric patients with treatment-resistant depression","volume":"251","author":"Buspavanich","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122322_bb0055","article-title":"Prevalence, progress, and subgroup disparities in pharmacological antidepressant treatment of those who screen positive for depressive symptoms: a repetitive cross-sectional study in 19 European countries","volume":"17","author":"Chen","year":"2022","journal-title":"Lancet Reg. Health Europe"},{"key":"10.1016\/j.jad.2026.122322_bb0060","article-title":"Antidepressant use and risk of adverse outcomes in older people: population based cohort study","volume":"343","author":"Coupland","year":"2011","journal-title":"BMJ (Online)"},{"key":"10.1016\/j.jad.2026.122322_bb0065","article-title":"A study of the safety and harms of antidepressant drugs for older people: a cohort study using a large primary care database","volume":"15","author":"Coupland","year":"2011","journal-title":"Health Technol. Assess. (Rockv)"},{"key":"10.1016\/j.jad.2026.122322_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/wps.20701","article-title":"A network meta-analysis of the effects of psychotherapies, pharmacotherapies and their combination in the treatment of adult depression","volume":"19","author":"Cuijpers","year":"2020","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jad.2026.122322_bb0075","doi-asserted-by":"crossref","DOI":"10.1111\/bcp.12596","article-title":"Adverse drug reactions in special populations - the elderly","volume":"80","author":"Davies","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jad.2026.122322_bb0080","article-title":"Antidepressant prescription for major depressive disorder: results from a population-based study in Italy","volume":"20","author":"Dell\u2019Osso","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jad.2026.122322_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.euroneuro.2011.07.004","article-title":"Agomelatine: a narrative review","author":"Demyttenaere","year":"2011","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2026.122322_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2021.09.063","article-title":"Pregabalin augmentation of antidepressants in major depression - results from a European multicenter study","volume":"296","author":"Dold","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122322_bb0095","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-021-01062-9","article-title":"Genetic and clinical characteristics of treatment-resistant depression using primary care records in two UK cohorts","volume":"26","author":"Fabbri","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2026.122322_bb0100","doi-asserted-by":"crossref","DOI":"10.1111\/acps.13803","article-title":"Confusional states during electroconvulsive therapy for late-life depression: a prospective cohort study","volume":"152","author":"Feenstra","year":"2025","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2026.122322_bb0105","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2014.6930","article-title":"Falls and fractures with atypical antipsychotic medication use: a population-based cohort study","author":"Fraser","year":"2015","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.jad.2026.122322_bb0110","doi-asserted-by":"crossref","DOI":"10.1186\/s12877-017-0674-2","article-title":"Potentially inappropriate prescriptions for elderly people taking antidepressant: comparative tools","volume":"17","author":"Fulone","year":"2017","journal-title":"BMC Geriatr."},{"key":"10.1016\/j.jad.2026.122322_bb0115","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.13m08675","article-title":"National trends in second-generation antipsychotic augmentation for nonpsychotic depression","volume":"75","author":"Gerhard","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2026.122322_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0239206","article-title":"Mortality risk of antipsychotic augmentation for adult depression","volume":"15","author":"Gerhard","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jad.2026.122322_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/gps.4065","article-title":"Psychotic major depression in older people: a systematic review","author":"Gournellis","year":"2014","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jad.2026.122322_bb0130","doi-asserted-by":"crossref","DOI":"10.1111\/bcpt.12062","article-title":"Medication reviews by clinical pharmacists at hospitals lead to improved patient outcomes: a systematic review","volume":"112","author":"Graab\u00e6k","year":"2013","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.jad.2026.122322_bb0135","article-title":"Twenty-three years of declining lithium use: analysis of a pharmacoepidemiological dataset from German-speaking countries","author":"Greil","year":"2024","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jad.2026.122322_bb0140","article-title":"The AMSP drug safety program: methods and global results","volume":"37","author":"Grohmann","year":"2004","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jad.2026.122322_bb0145","doi-asserted-by":"crossref","DOI":"10.1007\/s00406-013-0419-y","article-title":"Flupentixol use and adverse reactions in comparison with other common first- and second-generation antipsychotics: data from the AMSP study","volume":"264","author":"Grohmann","year":"2014","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2026.122322_bb0150","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-020-02514-2","article-title":"How well do elderly patients with major depressive disorder respond to antidepressants: a systematic review and single-group meta-analysis","volume":"20","author":"Gutsmiedl","year":"2020","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2026.122322_bb0155","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-019-2178-4","article-title":"Antidepressant prescription practice and related factors in Switzerland: a cross-sectional analysis of health claims data","volume":"19","author":"Haller","year":"2019","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2026.122322_bb0160","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2021.4313","article-title":"Combining antidepressants vs antidepressant monotherapy for treatment of patients with acute depression: a systematic review and meta-analysis","author":"Henssler","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2026.122322_bb0165","doi-asserted-by":"crossref","DOI":"10.1002\/alz.074601","article-title":"Benzodiazepine use in relation to long-term dementia risk and imaging markers of neurodegeneration: a population-based cohort study","volume":"19","author":"Hofe","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jad.2026.122322_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurger.2012.04.007","article-title":"Benzodiazepine use in Denmark 1997-2008","volume":"3","author":"Holm","year":"2012","journal-title":"Eur. Geriatr. Med."},{"key":"10.1016\/j.jad.2026.122322_bb0175","article-title":"Prevalence of depression in older adults: a systematic review and meta-analysis","author":"Hu","year":"2022","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2026.122322_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2023.04.110","article-title":"Do sociodemographic and clinical factors affect the selection of initial antidepressant treatment for depression in older adults? Results from a nationwide descriptive study in Denmark","volume":"334","author":"Ishtiak-Ahmed","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122322_bb0185","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ajp.20230356","article-title":"Real-world evidence on clinical outcomes of commonly used antidepressants in older adults initiating antidepressants for depression: a nationwide cohort study in Denmark","volume":"181","author":"Ishtiak-Ahmed","year":"2024","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.122322_bb0190","doi-asserted-by":"crossref","DOI":"10.1007\/s00228-023-03563-8","article-title":"Usefulness of mirtazapine and SSRIs in late-life depression: post hoc analysis of the GUNDAM study","volume":"79","author":"Kato","year":"2023","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jad.2026.122322_bb0195","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2021.3170","article-title":"Lithium treatment in the prevention of repeat suicide-related outcomes in veterans with major depression or bipolar disorder: a randomized clinical trial","volume":"79","author":"Katz","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2026.122322_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-019-0585-z","article-title":"Prospective biomarkers of major depressive disorder: a systematic review and meta-analysis","author":"Kennis","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2026.122322_bb0205","article-title":"Management of depression in older adults: a review","author":"Kok","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jad.2026.122322_bb0210","doi-asserted-by":"crossref","DOI":"10.1093\/geronb\/57.1.P87","article-title":"Negative life events and depression in elderly persons: a meta-analysis","volume":"57","author":"Kraaij","year":"2002","journal-title":"J Gerontol B Psychol Sci Soc Sci."},{"key":"10.1016\/j.jad.2026.122322_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/S2215-0366(16)30263-2","article-title":"Why is depression more common among women than among men?","author":"Kuehner","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2026.122322_bb0220","doi-asserted-by":"crossref","DOI":"10.2147\/NDT.S290104","article-title":"Benzodiazepine and z-drug use in Switzerland: prevalence, prescription patterns and association with adverse healthcare outcomes","volume":"17","author":"Landolt","year":"2021","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2026.122322_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2024.116114","article-title":"Antidepressants for treating depression among older adults with dementia: a systematic review and meta-analysis","author":"Lenouvel","year":"2024","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2026.122322_bb0230","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2204462","article-title":"Antidepressant augmentation versus switch in treatment-resistant geriatric depression","volume":"388","author":"Lenze","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2026.122322_bb0235","doi-asserted-by":"crossref","DOI":"10.1002\/gps.5861","article-title":"Use of benzodiazepine and Z-drugs and mortality in older adults after myocardial infarction","volume":"38","author":"Liu","year":"2023","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jad.2026.122322_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.euroneuro.2019.09.266","article-title":"P.223 treatment resistant depression in Stockholm: disease burden estimations, treatment trajectories and healthcare consumption from a longitudinal population-based cohort","volume":"29","author":"Lundberg","year":"2019","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2026.122322_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2010.11.033","article-title":"Age- and gender-specific prevalence of depression in latest-life - systematic review and meta-analysis","author":"Luppa","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122322_bb0250","article-title":"Potentially inadequate medications in the elderly: PRISCUS 2.0\u2014first update of the PRISCUS list","author":"Mann","year":"2023","journal-title":"Dtsch. Arztebl. Int."},{"key":"10.1016\/j.jad.2026.122322_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.mayocp.2016.07.024","article-title":"Benzodiazepine use in older adults: dangers, management, and alternative therapies","author":"Markota","year":"2016","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jad.2026.122322_bb0260","doi-asserted-by":"crossref","DOI":"10.1097\/YCT.0b013e3181faaeca","article-title":"A systematic review of the combined use of electroconvulsive therapy and psychotherapy for depression","author":"McClintock","year":"2011","journal-title":"J. ECT"},{"key":"10.1016\/j.jad.2026.122322_bb0265","doi-asserted-by":"crossref","DOI":"10.1007\/s12325-015-0207-3","article-title":"Real-world determinants of adjunctive antipsychotic prescribing for patients with major depressive disorder and inadequate response to antidepressants: a case review study","volume":"32","author":"McIntyre","year":"2015","journal-title":"Adv. Ther."},{"key":"10.1016\/j.jad.2026.122322_bb0270","doi-asserted-by":"crossref","DOI":"10.1001\/archgenpsychiatry.2009.175","article-title":"National trends in psychotropic medication polypharmacy in office-based psychiatry","volume":"67","author":"Mojtabai","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2026.122322_bb0275","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-clinpsy-072220-021440","article-title":"Major depression and its recurrences: life course matters","author":"Monroe","year":"2022","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"10.1016\/j.jad.2026.122322_bb0280","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ajp.2009.09030312","article-title":"Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials","author":"Nelson","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.122322_bb0285","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-021-01413-6","article-title":"Genetic heterogeneity and subtypes of major depression","volume":"27","author":"Nguyen","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2026.122322_bb0290","doi-asserted-by":"crossref","DOI":"10.1177\/070674370605100506","article-title":"Systematic overview of drug interactions with antidepressant medications","author":"Nieuwstraten","year":"2006","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.jad.2026.122322_bb0295","article-title":"Long-term antidepressant use in a cohort of older people","volume":"36","author":"O\u2019Neill","year":"2021","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jad.2026.122322_bb0300","doi-asserted-by":"crossref","DOI":"10.1186\/s13722-025-00579-6","article-title":"Pharmacotherapy of psychiatric inpatients with mental and behavioral disorders caused by sedatives or hypnotics (F13): results from an observational pharmacovigilance program between 2000 and 2017","volume":"20","author":"Pauwels","year":"2025","journal-title":"Addict. Sci. Clin. Pract."},{"key":"10.1016\/j.jad.2026.122322_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/S2215-0366(23)00262-6","article-title":"Antidepressant and antipsychotic side-effects and personalised prescribing: a systematic review and digital tool development","volume":"10","author":"Pillinger","year":"2023","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2026.122322_bb0310","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2304145","article-title":"Esketamine nasal spray versus quetiapine for treatment-resistant depression","volume":"389","author":"Reif","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2026.122322_bb0315","doi-asserted-by":"crossref","DOI":"10.1111\/jgs.12216","article-title":"Fracture risk in nursing home residents initiating antipsychotic medications","volume":"61","author":"Rigler","year":"2013","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.jad.2026.122322_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.psc.2013.08.007","article-title":"The role of electroconvulsive and neuromodulation therapies in the treatment of geriatric depression","author":"Riva-Posse","year":"2013","journal-title":"Psychiatr. Clin. N. Am."},{"key":"10.1016\/j.jad.2026.122322_bb0325","doi-asserted-by":"crossref","DOI":"10.1111\/psyg.12940","article-title":"Sedatives and analgesics are major contributors to potentially inappropriate duplicate prescriptions in geriatric psychiatry*","volume":"23","author":"Schulze Westhoff","year":"2023","journal-title":"Psychogeriatrics"},{"key":"10.1016\/j.jad.2026.122322_bb0330","doi-asserted-by":"crossref","DOI":"10.1186\/s12991-024-00530-0","article-title":"Psychotropic drug-induced adverse drug reactions in 462,661 psychiatric inpatients in relation to age: results from a German drug surveillance program from 1993\u20132016","volume":"23","author":"Seifert","year":"2024","journal-title":"Ann. General Psychiatry"},{"key":"10.1016\/j.jad.2026.122322_bb0335","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMcp2305428","article-title":"Treatment-resistant depression in older adults","volume":"390","author":"Steffens","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2026.122322_bb0340","doi-asserted-by":"crossref","DOI":"10.1192\/bjo.2021.192","article-title":"Treatment resistant depression in the UK: sub-analysis of a European real-world evidence study","volume":"7","author":"Talbot","year":"2021","journal-title":"BJPsych Open"},{"key":"10.1016\/j.jad.2026.122322_bb0345","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-027663","article-title":"Multinational comparison of new antidepressant use in older adults: a cohort study","volume":"9","author":"Tamblyn","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.jad.2026.122322_bb0350","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMcp1402180","article-title":"Clinical practice. Depression in the elderly","volume":"371","author":"Taylor","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2026.122322_bb0355","doi-asserted-by":"crossref","DOI":"10.1017\/S1041610216001307","article-title":"Patterns of psychotropic prescribing and polypharmacy in older hospitalized patients in Ireland: the influence of dementia on prescribing","volume":"28","author":"Walsh","year":"2016","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.jad.2026.122322_bb0360","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2022.0020","article-title":"Characterizing heterogeneity in neuroimaging, cognition, clinical symptoms, and genetics among patients with late-life depression","volume":"79","author":"Wen","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2026.122322_bb2000","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1136\/bmj.q1957","article-title":"Valproate: Men are advised to use contraception owing to risk of neurodevelopmental disorders in children","volume":"386","author":"Wise","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2026.122322_bb0365","article-title":"Concordance of the treatment patterns for major depressive disorders between the Canadian Network for Mood and Anxiety Treatments (CANMAT) algorithm and real-world practice in China","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jad.2026.122322_bb0370","doi-asserted-by":"crossref","DOI":"10.1007\/s41999-021-00481-9","article-title":"Adverse drug reactions in older adults: a narrative review of the literature","author":"Zazzara","year":"2021","journal-title":"Eur. Geriatr. Med."},{"key":"10.1016\/j.jad.2026.122322_bb0375","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.20m13699","article-title":"The prevalence and national burden of treatment-resistant depression and major depressive disorder in the United States","volume":"82","author":"Zhdanava","year":"2021","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2026.122322_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamda.2023.07.016","article-title":"Deprescribing interventions for older patients: a systematic review and meta-analysis","author":"Zhou","year":"2023","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.jad.2026.122322_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2019.10.051","article-title":"Prevalence and clinical correlates of psychotic depression in first-episode and drug-na\u00efve outpatients with major depressive disorder in a Chinese Han population","volume":"263","author":"Zhou","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122322_bb0390","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-019-2177-5","article-title":"Antipsychotic drug use and risk of stroke and myocardial infarction: a systematic review and meta-analysis","author":"Zivkovic","year":"2019","journal-title":"BMC Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726011754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726011754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:01:28Z","timestamp":1793383288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032726011754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":79,"alternative-id":["S0165032726011754"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2026.122322","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological treatment of late-life major depressive disorder \u2013 Results from the AMSP drug surveillance program from 2007 to 2023","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2026.122322","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"122322"}}